JP2001523648A5 - - Google Patents

Download PDF

Info

Publication number
JP2001523648A5
JP2001523648A5 JP2000520816A JP2000520816A JP2001523648A5 JP 2001523648 A5 JP2001523648 A5 JP 2001523648A5 JP 2000520816 A JP2000520816 A JP 2000520816A JP 2000520816 A JP2000520816 A JP 2000520816A JP 2001523648 A5 JP2001523648 A5 JP 2001523648A5
Authority
JP
Japan
Prior art keywords
fibrinogen
factor viii
carrier
microcapsules
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000520816A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001523648A (ja
Filing date
Publication date
Priority claimed from GBGB9724143.4A external-priority patent/GB9724143D0/en
Application filed filed Critical
Publication of JP2001523648A publication Critical patent/JP2001523648A/ja
Publication of JP2001523648A5 publication Critical patent/JP2001523648A5/ja
Pending legal-status Critical Current

Links

JP2000520816A 1997-11-14 1998-11-16 ２種の活性剤を含むコンジュゲート Pending JP2001523648A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9724143.4A GB9724143D0 (en) 1997-11-14 1997-11-14 Pharmaceutical conjugate
GB9724143.4 1997-11-14
PCT/GB1998/003442 WO1999025383A1 (en) 1997-11-14 1998-11-16 Conjugates comprising two active agents

Publications (2)

Publication Number Publication Date
JP2001523648A JP2001523648A (ja) 2001-11-27
JP2001523648A5 true JP2001523648A5 (https=) 2006-01-05

Family

ID=10822123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000520816A Pending JP2001523648A (ja) 1997-11-14 1998-11-16 ２種の活性剤を含むコンジュゲート

Country Status (9)

Country Link
US (1) US7001989B2 (https=)
EP (1) EP1047452B1 (https=)
JP (1) JP2001523648A (https=)
AT (1) ATE293459T1 (https=)
AU (1) AU1165899A (https=)
DE (1) DE69829880T2 (https=)
ES (1) ES2238774T3 (https=)
GB (1) GB9724143D0 (https=)
WO (1) WO1999025383A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933366B2 (en) * 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
WO1999064072A1 (de) * 1998-06-10 1999-12-16 Baxter Aktiengesellschaft Konjugat, bestehend aus einem lektin und einem blutgerinnungsfaktor
GB9825105D0 (en) * 1998-11-16 1999-01-13 Andaris Ltd Pharamaceutical conjugates
GB9827813D0 (en) * 1998-12-17 1999-02-10 Andaris Ltd Pharmaceutical conjugates
DE19926475A1 (de) * 1999-06-10 2000-12-14 Ktb Tumorforschungs Gmbh Träger-Pharmaka-Konjugate
AU6389000A (en) * 1999-07-28 2001-02-19 Valentis, Inc. Sonoporation of tumors
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
JP5230610B2 (ja) 2006-05-05 2013-07-10 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 二価ｓｍａｃ模倣物およびその使用
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US20090170195A1 (en) * 2007-12-28 2009-07-02 Kent State University Curcumin-hyaluronan compounds
CN102112144A (zh) 2008-05-16 2011-06-29 拜耳医药保健有限公司 靶向性凝固因子及其使用方法
JP5770161B2 (ja) * 2009-04-06 2015-08-26 ノヴォ ノルディスク アー／エス 血小板への第ｖｉｉｉ因子タンパク質の標的送達
GB201101740D0 (en) * 2011-02-01 2011-03-16 Haemostatix Ltd Therapeutic agents with improved fibrinogen binding

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970300A (en) * 1985-02-01 1990-11-13 New York University Modified factor VIII
IL85372A (en) * 1987-02-12 1992-12-01 Us Health Penta to nona-peptides with laminin - like activity having an amino acid sequence and anti- metastatic compositions containing them
WO1996039128A1 (en) 1995-06-06 1996-12-12 Hemosphere, Inc. Protein particles for therapeutic and diagnostic use
US5716614A (en) * 1994-08-05 1998-02-10 Molecular/Structural Biotechnologies, Inc. Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
PT796090E (pt) * 1994-12-16 2003-07-31 Elan Drug Delivery Ltd Microparticulas reticuladas e sua utilizacao como veiculos terapeuticos
ES2232862T3 (es) * 1996-10-21 2005-06-01 Quadrant Drug Delivery Limited Sustitutos de plaquetas y procedimientos de conjugacion apropiados para su preparacion.

Similar Documents

Publication Publication Date Title
Marshall Manipulation of the properties of enzymes by covalent attachment of carbohydrate
JP2001523648A5 (https=)
DE69731985T2 (de) Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren
Muzykantov et al. Immunotargeting of antioxidant enzyme to the pulmonary endothelium.
AU730122B2 (en) Multimeric erythropoietin with increased biological activity
CZ183797A3 (en) Cross-linked micro-particles and their use as a therapeutic carrier
JP2013500238A (ja) 第ｆｖｉｉｉ因子ポリマー結合体
JPH07500315A (ja) 骨成長因子の標的送達
EP1047452B1 (en) Conjugates comprising two active agents
JP2002515447A (ja) 抑制されない血管内フィブリンクロット形成の予防および治療のための組成物および方法
CA2113206A1 (en) Modified pf4 compositions and methods of use
JPH05238951A (ja) モルホリノアントラサイクリンの抗体への化学結合
CA2323210A1 (en) Enhancement of intracellular delivery and tissue targeting of drugs and genes
US20190240295A1 (en) Factor viii with extended half-life and reduced ligand-binding properties
EP0485749A2 (en) Chemical modification of antibodies for creating of immunoconjugates
Muzykantov Conjugation of catalase to a carrier antibody via a streptavidinŐbiotin cross‐linker
AU754117B2 (en) Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells
WO2000035487A1 (en) Pharmaceutical conjugates comprising two active agents
WO2000029028A1 (en) Pharmaceutical conjugates of glycoproteins and insoluble carriers
AU2002255172B2 (en) Soluble protein-polymer systems for drug delivery
WO1997022879A1 (en) Modified avidin-type molecules as targeting agents for the liver and cells of the reticuloendothelial system
US20080306245A1 (en) Method For The Production Of Albumen Conjugates With Non-Steroidal Antirheumatic Drugs (Nsar)
AU2002255172A1 (en) Soluble protein-polymer systems for drug delivery
JP2018115170A (ja) 第ｆｖｉｉｉ因子ポリマー結合体
JPH0332356B2 (https=)